Reliability of resting-state electrophysiology in fragile X syndrome

Objective: Fragile X Syndrome (FXS) is the leading monogenic cause of intellectual disability and autism spectrum disorder. Currently, there are no established biomarkers for predicting and monitoring drug effects in FXS, and no approved therapies are available. Previous studies have shown electroph...

Повний опис

Бібліографічні деталі
Автори: Rui Liu, Ernest V. Pedapati, Lauren M. Schmitt, Rebecca C. Shaffer, Elizabeth G. Smith, Kelli C. Dominick, Lisa A. DeStefano, Grace Westerkamp, Paul Horn, John A. Sweeney, Craig A. Erickson
Формат: Стаття
Мова:English
Опубліковано: Elsevier 2023-12-01
Серія:Biomarkers in Neuropsychiatry
Предмети:
Онлайн доступ:http://www.sciencedirect.com/science/article/pii/S2666144623000102